Bristol Myers Squibb BMY
NYSE BMY
$61.48 -1.53 (-2.43%)
At close: Oct 23, 2026 · 4:00 PM EDT

Bristol Myers Squibb (BMY) Return on Invested Capital [ROIC] (2009 - 2026)

Updated

Bristol Myers Squibb's Return on Invested Capital [ROIC] was -3.32% in Q2 2026, up 5.38 percentage points from -8.70% a year earlier and up 2.27 percentage points from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Return on Invested Capital [ROIC] (2009 - 2026) Analysis & Trends

For FY2025, Return on Invested Capital [ROIC] at Bristol Myers Squibb came in at -5.38%, up 27.66 percentage points from FY2024.

  • Return on Invested Capital [ROIC] shows a five-year change of +14.56 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Invested Capital [ROIC] was -33.03% in FY2024 (-29.96 pp), -3.07% in FY2023 (-0.43 pp), -2.64% in FY2022 (-0.75 pp) and -1.89% in FY2021 (+18.05 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Invested Capital [ROIC] since Q4 2023.
  • Compared with a year earlier, Return on Invested Capital [ROIC] has increased for six straight quarters, with an average year-over-year change of +4.17 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Invested Capital [ROIC] over five years was Q4 2025 (a gain of 28.29 percentage points); the worst was Q4 2024 (a drop of 30.45 percentage points).
  • Per Business Quant data, BMY's Return on Invested Capital [ROIC] in the three quarters before Q2 2026 was -5.59% (Q1 2026), -5.31% (Q4 2025) and -7.42% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.57%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 18.68%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 3.56%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 34.87%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 23.26%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 14.33%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -5.97%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 13.44%
10 Bristol Myers Squibb 125.59 Bn 76.86 Bn 9.25 Bn -3.32%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.32%
Mar 31, 2026 -5.59%
Dec 31, 2025 -5.31%
Sep 30, 2025 -7.42%
Jun 30, 2025 -8.70%
Mar 31, 2025 -10.64%
Dec 31, 2024 -33.61%
Sep 30, 2024 -27.54%
Jun 30, 2024 -25.22%
Mar 31, 2024 -23.90%
Dec 31, 2023 -3.16%
Sep 30, 2023 -2.71%
Jun 30, 2023 -2.22%
Mar 31, 2023 -1.71%
Dec 31, 2022 -2.80%
Sep 30, 2022 -2.59%
Jun 30, 2022 -2.49%
Mar 31, 2022 -2.54%
Dec 31, 2021 -1.96%
Sep 30, 2021 -17.93%
API Access

Bristol Myers Squibb Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=BMY&period=max&api_key=YOUR_API_KEY